Evolus Inc (EOLS)

01:22 AM

BioPharma Credit – Partial loan repayment and expanded Evolus facility - QuotedData

01:22 AM

May 05, 2025

Evolus Secures New $250 Million Credit Facility - TipRanks

May 05, 2025

May 05, 2025

Evolus IncEnters New $250 Million Credit Facility With Pharmakon Advisors, Replacing Exisiting $125 Million Credit Agreement - marketscreener.com

May 05, 2025

May 05, 2025

Evolus Strengthens Balance Sheet with Refinancing; Reducing Cost of Capital and Expanding Financial Flexibility | EOLS Stock News - GuruFocus

May 05, 2025

May 05, 2025

Evolus Strengthens Balance Sheet with Refinancing; Reducing Cost of Capital and Expanding Financial Flexibility - Business Wire

May 05, 2025

May 03, 2025

Analysts Offer Insights on Healthcare Companies: Align Tech (ALGN), Evolus (EOLS) and Becton Dickinson (BDX) - The Globe and Mail

May 03, 2025

Apr 30, 2025

Will Evolus, Inc. (EOLS) Report Negative Earnings Next Week? What You Should Know - Yahoo Finance

Apr 30, 2025

Apr 30, 2025

When Will Evolus, Inc. (NASDAQ:EOLS) Breakeven? - simplywall.st

Apr 30, 2025

Apr 29, 2025

Evolus Inc (EOLS) Shares Gap Down to $11.115 on Apr 28 - GuruFocus

Apr 29, 2025

Apr 25, 2025

Midday Stock Roundup: FivePoint Rises on Earnings - Orange County Business Journal

Apr 25, 2025

Apr 23, 2025

Evolus to Report First Quarter Financial Results on May 7, 2025 - BioSpace

Apr 23, 2025

Apr 22, 2025

Evolus: Two-Product Aesthetics Company With A Competitive Edge (NASDAQ:EOLS) - Seeking Alpha

Apr 22, 2025

Apr 18, 2025

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | EOLS Stock News - GuruFocus

Apr 18, 2025

Apr 18, 2025

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Apr 18, 2025

Apr 18, 2025

Evolus announces commercial launch of Evolysse - MSN

Apr 18, 2025

Apr 17, 2025

BTIG Initiates Coverage of Evolus (EOLS) with Buy Recommendation - Nasdaq

Apr 17, 2025

Apr 17, 2025

BTIG Initiates Evolus at Buy With $21 Price Target - marketscreener.com

Apr 17, 2025

Apr 17, 2025

Evolus initiated with a Buy at BTIG - TipRanks

Apr 17, 2025

Apr 17, 2025

BTIG Initiates Coverage on Evolus (EOLS) with Optimistic Outlook | EOLS Stock News - GuruFocus

Apr 17, 2025

Apr 17, 2025

BTIG Initiates Coverage on Evolus (EOLS) with Optimistic Outlook - GuruFocus

Apr 17, 2025

Apr 16, 2025

Evolus Launches "Drop The F Word" To Redefine Aesthetic Injectables With Evolysse - Nasdaq

Apr 16, 2025

Apr 16, 2025

Evolus Announces Commercial Launch of Evolysse™ | EOLS Stock New - GuruFocus

Apr 16, 2025

Apr 16, 2025

Evolus Announces Commercial Launch of Evolysse™ - Yahoo Finance

Apr 16, 2025

Apr 16, 2025

Evolus Launches “Drop the F Word” Campaign in Advance of the Com - GuruFocus

Apr 16, 2025

Apr 15, 2025

Game-Changing Cold-X Technology: Evolus Revolutionizes Injectable Aesthetics with Natural Results - Stock Titan

Apr 15, 2025

Apr 10, 2025

Midday Stock Roundup: Evolus, ICU Medical down - Orange County Business Journal

Apr 10, 2025

Apr 10, 2025

H.C. Wainwright maintains Buy on Evolus stock with $27 target - Investing.com

Apr 10, 2025

Apr 10, 2025

H.C. Wainwright maintains Buy on Evolus stock with $27 target By Investing.com - Investing.com Canada

Apr 10, 2025

Apr 09, 2025

Evolus stock hits 52-week low at $9.22 amid market challenges - Investing.com Canada

Apr 09, 2025

Apr 09, 2025

Evolus stock hits 52-week low at $9.22 amid market challenges By Investing.com - Investing.com South Africa

Apr 09, 2025

Apr 09, 2025

Breaking Down Evolus: 8 Analysts Share Their Views - Benzinga

Apr 09, 2025

Apr 09, 2025

Investors Give Evolus, Inc. (NASDAQ:EOLS) Shares A 31% Hiding - simplywall.st

Apr 09, 2025

Apr 08, 2025

Evolus at Needham Conference: Strategic Launch of Evolisse By Investing.com - Investing.com Canada

Apr 08, 2025

Apr 08, 2025

Evolus at Needham Conference: Strategic Launch of Evolisse - Investing.com

Apr 08, 2025

Apr 07, 2025

Sandra Beaver: Evolus on Track to Hit $700M Revenue - Orange County Business Journal

Apr 07, 2025

Apr 06, 2025

Recent 11% pullback isn't enough to hurt long-term Evolus (NASDAQ:EOLS) shareholders, they're still up 170% over 5 years - simplywall.st

Apr 06, 2025

Apr 02, 2025

Evolus, Inc.: Navigating Financial Challenges Amidst Ongoing Losses and Market Uncertainty - MSN

Apr 02, 2025

Mar 29, 2025

Evolus CEO David Moatazedi sells $77,512 in stock By Investing.com - Investing.com India

Mar 29, 2025

Mar 28, 2025

Evolus CEO David Moatazedi sells $77,512 in stock - Investing.com Australia

Mar 28, 2025

Mar 25, 2025

Evolus to Participate in The Needham 24th Annual Virtual Healthcare Conference - BioSpace

Mar 25, 2025

Mar 25, 2025

Evolus Inc (EOLS) Shares Down 4.54% on Mar 25 - GuruFocus

Mar 25, 2025

Mar 23, 2025

Investing in Evolus (NASDAQ:EOLS) five years ago would have delivered you a 216% gain - Yahoo

Mar 23, 2025

Mar 21, 2025

Evolus reports inducement grants under Nasdaq listing rule 5635(C)(4) -March 21, 2025 at 04:17 pm EDT - MarketScreener

Mar 21, 2025

Mar 21, 2025

Evolus director David Moatazedi sells $1.37 million in stock By Investing.com - Investing.com Australia

Mar 21, 2025

Mar 21, 2025

Evolus Growth Continues: 14 New Employees Join as Company Strengthens Talent Pool - Stock Titan

Mar 21, 2025